2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Jaw Cysts: new trials by email Literature Review of Jaw Cysts trials Research Report on Jaw Cysts
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome Patidegib Topical Gel, Patidegib Topical Gel with no active patidegib - Gorlin Syndrome | Phase 3 | Completed | Sol-Gel Technologies, Ltd. | 113 | 2024-03-17 | 2026-09-18 |
| Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome) Patidegib Topical Gel, 2%, Patidegib Topical Gel, Vehicle - Basal Cell Nevus Syndrome | Phase 3 | Completed | Sol-Gel Technologies, Ltd. | 174 | 2019-02-19 | 2024-07-03 |
Basal Cell Nevus Syndrome (2) · Carcinoma, Basal Cell (1)
Abnormalities, Multiple (2) · Bone Cysts (2) · Bone Diseases (2) · Bone Diseases, Developmental (2) · Carcinoma (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cysts (2) · Genetic Diseases, Inborn (2) · Jaw Diseases (2) · Musculoskeletal Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Basal Cell (2)
IPI-926 (1)
Sol-Gel Technologies, Ltd. (2)
France (2) · Germany (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Belgium (1) · Canada (1) · Denmark (1)
2023 (1)